Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal ADRB1 Primary Antibody for ELISA, WB - ABIN185584
Chandra, Portbury, Ray, Ream, Groelle, Chikaraishi: Beta1-adrenergic receptors maintain fetal heart rate and survival. in Biology of the neonate 2006
Show all 4 Pubmed References
Human Polyclonal ADRB1 Primary Antibody for ELISA, WB - ABIN269984
Wallukat, Muñoz Saravia, Haberland, Bartel, Araujo, Valda, Duchen, Diaz Ramirez, Borges, Schimke: Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients. in Journal of the American College of Cardiology 2010
Show all 2 Pubmed References
Human Polyclonal ADRB1 Primary Antibody for IF (p), IHC (p) - ABIN669351
Deng, Liu, Zhang, Wang, Peng, Wei, Jiang: Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model. in Journal of experimental & clinical cancer research : CR 2014
Show all 2 Pubmed References
Dog (Canine) Polyclonal ADRB1 Primary Antibody for WB - ABIN2774823
Tsai, Lee, Chen, Kao, Lu, Lin, Chen, Chen: Testosterone replacement increases aged pulmonary vein and left atrium arrhythmogenesis with enhanced adrenergic activity. in International journal of cardiology 2014
Show all 2 Pubmed References
Dog (Canine) Polyclonal ADRB1 Primary Antibody for ELISA, IF - ABIN1582290
Stiles, Amaya, Rains, Diaz, Pham, Battiste, Modiano, Kokta, Boucheron, Mitchell, Bryan: Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma. in PLoS ONE 2013
Zebrafish larvae lacking beta1AR expression by morpholino knockdown displayed lower heart rates than control fish, whereas larvae deficient in both beta2aAR and beta2bAR expression exhibited significantly higher heart rates than controls.
ghrelin (show GHRL Antibodies) has a critical role in preventing hypoglycemia and promoting survival during severe caloric restriction, a process that requires cell-expressed beta1AR
knocking out of the beta1/2 (show TFAP2B Antibodies) receptor significantly diminished the ST25 acupuncture-induced inhibition of gastric motility and jejunal motility without significantly altering the enhancement of colonic motility induced by acupuncture at ST25.
Our findings that BAG3 (show BAG3 Antibodies) is localized at the sarcolemma and t-tubules while modulating myocyte contraction and action potential duration through specific interaction with the beta1-adrenergic receptor and L-type Ca(2 (show CA2 Antibodies)+) channel provide novel insight into the role of BAG3 (show BAG3 Antibodies) in cardiomyopathies and increased arrhythmia risks in heart failure.
Galphai2 (show GNAI2 Antibodies) deficiency combined with cardiac beta1-adrenoceptor overexpression strongly impaired survival and cardiac function, leading to dilated cardiomyopathy.
Knockout of the C5aR1 (show C5AR1 Antibodies) attenuated the effect of beta1-AR in the heart, suggesting an association between the beta1-AR and C5aR1 (show C5AR1 Antibodies), although further investigation is required to determine if this is a direct or causal association
Partial gap junction uncoupling increased propensity and amplitude of Ca(2 (show CA2 Antibodies)+) alternans, and made them more sensitive to reversal by beta-AR activation, as in isolated myocytes.
These data reveal a novel interplay between the E2F pathway, beta2-adrenergic/PKA/PDE4D, and ERK/c-Src axis in fine tuning the pathological hypertrophic growth response.
Myocardial adrenergic receptor beta 1 preferentially associates with AC5 (show ADCY5 Antibodies).
role of beta-ARs (show SLURP1 Antibodies) in early muscle regeneration
Phosphorylation of beta1-AR by PKA stimulates active Ca(2 (show CA2 Antibodies)+)influx through TRPV5 (show TRPV5 Antibodies).
two barcodes are involved in sorting Wild Type ss1-AR out of early endosomes.
Data suggest that the partial agonist STD (show SULT2A1 Antibodies)-101-D1 of beta-1 adrenergic receptor (ADRB1) is an research tool to study mechanisms of G protein-coupled receptor (show ADRA1A Antibodies) signal transduction.
Analyzing the functional relevance of individual sites using phosphosite-deficient receptor mutants we found phosphorylation of the ADRB1 at Ser461/Ser462 in the distal part of the C-terminus to determine beta-arrestin2 (show ARRB2 Antibodies) recruitment and receptor internalization
Studied frequency of ADRB1 Arginine389Glycine (Arg389Gly) and Cytochrome p450 2D6 (show CYP2D6 Antibodies)*10 (Cyp2D6 (show CYP2D6 Antibodies)*10) polymorphism in cases of heart failure-reduced ejection fraction (HFREF), and to evaluate the influence of the polymorphisms in response to beta-blocker (BB) therapy; found a statistically significant association was observed with CC genotype and Glisin-Glisin (GG) genotype.
Among individuals with previous small artery ischemic stroke, the ADRB1 Gly49 polymorphism was associated with major adverse cardiovascular events, particularly small artery ischemic stroke, a risk that may be increased among beta-blocker-treated individuals.
ADRB1 SNPs were associated with myocardial infarction susceptibility, blood pressure and plasma lipids.
the beta adrenoreceptor Gly 49 allele of the beta1 -adrenergic receptor Ser (show SIGLEC1 Antibodies)(49) Gly polymorphisms may increase the risk of implantable cardioverter-defibrillators shock in patients with heart failure, independent of beta-blocker dosage
This study demonstrates that the polypeptide GalNAc-transferase 2 (GalNAc-T2 (show GALNT2 Antibodies)) specifically O-glycosylates beta 1-adrenergic receptor at five residues in the extracellular N terminus, including the Ser (show SIGLEC1 Antibodies)-49 residue at the location of the common S49G single-nucleotide polymorphism.
The minor alleles of ADRB1 and ADRB3 (show ADRB3 Antibodies) were significantly underrepresented in kinesiology students compared with nonmajors.
The ADRB1 Gly389X genotype showed greater response to bisoprolol than the Arg389Arg genotype, suggesting the potential of individually tailoring beta-blocker therapy according to genotype in Korean heart failure patients.
The adrenergic receptors (subtypes alpha 1, alpha 2, beta 1, and beta 2) are a prototypic family of guanine nucleotide binding regulatory protein-coupled receptors that mediate the physiological effects of the hormone epinephrine and the neurotransmitter norepinephrine. Specific polymorphisms in this gene have been shown to affect the resting heart rate and can be involved in heart failure.
beta-adrenergic receptor kinase 1
, adrenergic, beta-1-, receptor
, adrenoceptor beta 1
, adrenoceptor beta 3
, beta adrenergic receptor kinase 1
, beta-1-adrenergic receptor
, beta-1 adrenergic receptor
, tripartite motif-containing 75
, adrenergic, beta, receptor kinase 1
, beta-adrenergic receptor kinase 1-like
, beta1-adrenergic G-protein-coupled receptor
, beta 1-AR
, beta-1 adrenoceptor
, beta-1 adrenoreceptor
, cardiac beta adrenergic receptor
, beta 1 adrenergic receptor
, adrenergic receptor, beta 1
, beta 1-adrenergic receptor beta 1-AR
, beta 1 adrenergic protein
, Beta-1 adrenergic receptor
, G-protein-coupled hormone receptor
, beta 1-adrenergic receptor